Muir-Torre syndrome: Confirmation of diagnosis by immunohistochemical analysis of cutaneous lesions [2]

Journal of the American Academy of Dermatology

Volumn 50, Issue 3, 2004, Pages 476-478

  Fiorentino, David F ^a,c   Nguyen, Josephine C ^a   Egbert, Barbara M ^a,b   Swetter, Susan M ^a,b  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN MLH1; PROTEIN MSH1; PROTEIN MSH2; UNCLASSIFIED DRUG;

ADULT; CASE REPORT; CLINICAL FEATURE; COLON ADENOCARCINOMA; COLON RESECTION; COLONOSCOPY; GENETIC ANALYSIS; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; MALE; MUIR TORRE SYNDROME; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN DEFECT;

EID: 1542284060     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2003.07.027     Document Type: Article

References (9)

1. Cohen PR, Kohn SR, Davis DA, Kurzrock R. Muir-Torre syndrome. Dermatol Clin 1995;13:79-89.
2. Schwartz RA, Torre DP. The Muir-Torre syndrome: a 25-year retrospect. J Am Acad Dermatol 1995;33:90-104.
3. Cohen PR, Kohn SR, Kurzrock R. Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome. Am J Med 1991;90:606-13.
4. Kruse R, Rutten A, Lamberti C, Hosseiny-Malayeri HR, Wang Y, Ruelfs C, et al. Muir-Torre phenotype has a frequency of DNA mismatch-repair-gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria. Am J Hum Genet 1998;63:63-70.
5. Akhtar S, Oza KK, Khan SA, Wright J. Muir-Torre syndrome: case report of a patient with concurrent jejunal and ureteral cancer and a review of the literature. J Am Acad Dermatol 1999;41:681-6.
6. Peris K, Onorati MT, Keller G, Magrini F, Donati P, Muscardin L, et al. Widespread microsatellite instability in sebaceous tumours of patients with the Muir-Torre syndrome. Br J Dermatol 1997;137:356-60.
7. Popnikolov NK, Gatalica Z, Colome-Grimmer MI, Sanchez RL. Loss of mismatch repair proteins in sebaceous gland tumors. J Cutan Pathol 2003;30:178-84.
8. Machin P, Catasus L, Pons C, Munoz J, Conde-Zurita JM, Balmana J, et al. Microsatellite instability and immunostaining for MSH-2 and MLH-1 in cutaneous and internal tumors from patients with the Muir-Torre syndrome. J Cutan Pathol 2002;29:415-20.
9. Mathiak M, Rutten A, Mangold E, Fischer HP, Ruzicka T, Friedl W, et al. Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test. Am J Surg Pathol 2002;26:338-43.